Eli Lilly has increased prices for all providers, which affects treatment costs. We’re working to keep pricing as competitive as possible ahead of changes from 1 September.

We’re finalising our updated pricing. No changes apply before 31 August, subject to stock. We’ll publish updates once confirmed.

Some patients can remain on Mounjaro at a lower dose to reduce cost. Others may consider alternatives such as Wegovy or Saxenda. Trials suggest average weight loss of ~17% with Wegovy; individual results vary. Our clinical team can help you choose a suitable option.

Both are effective. Trials suggest ~20% average weight loss with Mounjaro and ~17% with Wegovy. The best choice depends on tolerability, goals, and budget.

Yes—Wegovy is a potent treatment. Pen dose numbers aren’t directly comparable across different medicines. What matters is the medicine, the right dose for that medicine, and consistency over time.

Yes. A 1-week (7-day) wash-out is typically advised before starting Wegovy. Your prescriber will confirm the timing that’s right for you.

To avoid overlapping effects and reduce the risk of side effects.

Generally 1 week (7 days) across dose levels.

Yes. Mounjaro (tirzepatide) and Wegovy (semaglutide) are different medicines, so a new consultation is required.

Yes. Follow the same 1-week wash-out and your prescriber’s guidance.

Yes, but you must start the starter dose of the new medicine.

Overlapping effects can increase side-effect risk and make dose titration harder to interpret.

It’s safe to delay beyond one week, but appetite may increase and some weight regain can occur. Keeping healthy habits helps mitigate this.

No. Begin at 0.25 mg once weekly, regardless of your previous Mounjaro dose.

0.25 mg weekly × 4 weeks → 0.5 mg × 4 → 1 mg × 4 → 1.7 mg × 4 → 2.4 mg maintenance. Some patients may remain longer at a given dose if effective and well-tolerated (at prescriber discretion).

Track hunger, satiety, and weight trends. Some patients see stronger effects at higher doses.

Unlikely over one week, but appetite may rise temporarily until your Wegovy dose becomes effective.

Yes—our pharmacists and dietitians are here to help throughout.

Common GI effects (nausea, diarrhoea/constipation, abdominal discomfort) are similar with both. Stay well hydrated and contact us if symptoms are significant or persistent.

Maintain healthy routines, avoid known trigger foods, and continue regular activity as tolerated.

It depends on the side effects. Please speak to a clinician before switching.

Yes—your prescriber must confirm suitability for Wegovy and issue a new prescription.

Specific long-term data on switching are limited, but the overall risk profile is expected to be similar to starting Wegovy directly.

That’s okay. Start the 0.25 mg dose when ready, provided you’ve observed the 1-week wash-out. Longer delays may increase appetite temporarily.

No. Eligibility is assessed case by case; switching itself doesn’t prevent future treatment.